01 30ARIPIPRAZOLE
02 30Aripiprazol
03 73Aripiprazole
04 10Aripiprazole (Anhydrous)
05 8Aripiprazole Monohydrate
06 12BREXPIPRAZOLE
07 4Brekspiprazole
08 11Brexpiprazol
09 12Brexpiprazole
10 1CEDAZURIDINE
11 1CEDAZURIDINE; DECITABINE
12 2CILOSTAZOL
13 1Cedazuridin; Decitabin
14 1Cedazuridine; Decitabine
15 2Cilostazol
16 1Ciprofloxacin
17 2DECITABINE
18 1DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE
19 1Decitabin; Cedazuridin
20 2Decitabine; Cedazuridine
21 7Delamanid
22 1FERRIC AMMONIUM CITRATE
23 2FUTIBATINIB
24 4Futibatinib
25 3GREPAFLOXACIN HYDROCHLORIDE
26 1IOHEXOL
27 1Metronidazole
28 2Paracetamol
29 2TIPIRACIL (TIPIRACIL HYDROCHLORIDE)
30 2TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE
31 20TOLVAPTAN
32 2TRIFLURIDINE
33 65Tolvaptan
34 8Tolvaptanum
35 2UREA C-13
36 5Voclosporin
37 1Voklosporin
01 1AVANIR PHARMS
02 1INTERPHARMA PRAHA AS
03 41OTSUKA
04 2OTSUKA AMERICA
05 10OTSUKA PHARMAC.EUROPE LTD
06 28OTSUKA PHARMACEUTICAL CO LTD
07 9OTSUKA PHARMACEUTICAL NETHERLANDS BV
08 14Otsuka Australia Pharmaceutical Pty. Ltd
09 7Otsuka Novel Products Gmbh
10 17Otsuka Pharmaceutical (Switzerland) Gmbh
11 2Otsuka Pharmaceutical Europe Limited
12 3Otsuka Pharmaceutical Europe Ltd
13 4Otsuka Pharmaceutical India Private Limited
14 31Otsuka Pharmaceutical Netherlands B.V.
15 29Otsuka Pharmaceutical Netherlands BV
16 119Otsuka Pharmaceutical Netherlands Bv
17 5TAIHO ONCOLOGY
18 6TAIHO PHARMA CANADA, INC.
19 1Taiho Pharma Netherlands B.V.
20 3Taiho Pharma Netherlands Bv
01 2Aripiprazole 10Mg 28 Combined Oral Use
02 2Aripiprazole 15Mg 28 Combined Oral Use
03 1Aripiprazole 1Mg/Ml 150Ml Oral Use
04 1Aripiprazole 400Mg 2 Ml 1 Units Parenteral Use Rp
05 1Aripiprazole 5Mg 28 Combined Oral Use
06 1Aripiprazole 9,75Mg 1,3Ml 1 Unit Parenteral Use
07 1CAPSULE;ORAL
08 4Capsule
09 7Dispersible Tablet
10 2Extended-Release Injectable Suspension In Prefilled Syringe
11 4FOR SOLUTION;ORAL
12 31Film Coated Tablet
13 10Film-Coated Tablet
14 1INJECTABLE;INTRAMUSCULAR
15 1INJECTABLE;INTRAVENOUS
16 4Infusion Solution
17 3Injectable Solution
18 1Injection Solution
19 1KIT
20 6Oral Solution
21 1Oral Solution Oral Use Pet
22 12Orodispersible Tablet
23 1POWDER FOR SUSPENSION, SUSTAINED-RELEASE
24 1Powder And Solvent For Extended-Release Injection Suspension
25 6Powder And Solvent For Injectable Extended-Release Suspension
26 8Powder And Solvent For Prolonged-Release Suspension For Injection
27 2Powder And Solvent For Prolonged-Release Suspension For Injection In Pre-Filled Syringe
28 2Prolonged Release Suspension For Injection In Pre-Filled Syringe
29 1SOLUTION;ORAL
30 2SUSPENSION (EXTENDED-RELEASE)
31 2SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
32 2Soft Capsule
33 6Solution For Injection
34 2Suspension For Injection
35 4Suspension In Pre-Filled Syringe
36 2Syrup
37 30TABLET
38 4TABLET, ORALLY DISINTEGRATING;ORAL
39 36TABLET;ORAL
40 109Tablet
41 1Tolvaptan 15Mg 10 Units Oral Use
42 1Tolvaptan 30Mg 10 Units Oral Use
43 4tablet
44 10Blank
01 20.25MG
02 20.25mg
03 10.50mg
04 30.5MG
05 20.5mg
06 11 mg/ml
07 11 vial IM 1,3 ml 7,5 mg/ml
08 11 vial IM 400 mg + 1 vial solv 2 ml sustained release
09 110 CPR 15 mg
10 110 CPR 30 mg
11 210 mg
12 1100MG
13 1100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
14 1100MG;35MG
15 1100mg
16 1110MG
17 110MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
18 1210mg
19 210mg/ml
20 1125MG/VIAL
21 215 mg
22 115 mg + 45 mg
23 2415MG
24 115MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
25 2115mg
26 115mg; 45mg
27 116MG
28 61MG
29 11MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
30 21mg
31 51mg/ml
32 120 mg
33 420MG
34 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
35 120MG;10MG
36 1250mcg
37 325mg
38 128 CPR 10 mg
39 128 CPR 15 mg
40 128 CPR 5 mg
41 128 cpr orodispers 10 mg
42 128 cpr orodispers 15 mg
43 62MG
44 32mg
45 12mg/ml
46 130 mg
47 130 mg + 60 mg
48 130 mg + 90 mg
49 2300MG
50 1300MG/VIAL
51 6300mg
52 1930MG
53 130MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
54 1830mg
55 130mg; 60mg
56 130mg; 90mg
57 135MG
58 135MG; 100 MG
59 335mg; 100mg
60 135mg;100mg
61 33MG
62 33mg
63 5400MG
64 1400MG/VIAL
65 8400mg
66 245MG
67 245MGMG; MGMG
68 245mg
69 145mg;15mg
70 54MG
71 54mg
72 150MG
73 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
74 150MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
75 450mg
76 45MG
77 65mg
78 16.14MG
79 1600MG/PACKET
80 260MG
81 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
82 160MGMG; MGMG
83 160mg
84 160mg;30mg
85 27.5MG
86 57.5mg
87 47.5mg/ml
88 17.9MG
89 47.9mg
90 1720MG
91 1720MG/2.4ML
92 1720MG/2.4ML (300MG/ML)
93 3720mg
94 1720mg/2.4ml
95 175mg
96 175mg/ml
97 179mg
98 18.19MG
99 19.75MG/1.3ML (7.5MG/ML)
100 19.7GM/BOT
101 290MG
102 390MGMG; MGMG
103 290mg
104 190mg;30mg
105 1960MG
106 1960MG/3.2ML
107 1960MG/3.2ML (300MG/ML)
108 3960mg
109 1960mg/3.2ml
110 1EQ 200MG BASE
111 1EQ 400MG BASE
112 1EQ 6.14MG BASE;15MG
113 1EQ 600MG BASE
114 1EQ 75MG/POUCH
115 1EQ 8.19MG BASE;20MG
116 1os soluz 1 Bottle 150 ml 1 mg/ml
117 23Blank
01 14Australia
02 34Canada
03 34Denmark
04 34Estonia
05 19Italy
06 4Moldova
07 29Norway
08 61Spain
09 37Sweden
10 17Switzerland
11 50USA
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Tablet
Brand Name : Abilify
Dosage Strength : 15MG
Packaging :
Approval Date : 21-02-2018
Application Number : 04276012IP
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Tablet
Brand Name : Abilify
Dosage Strength : 15MG
Packaging :
Approval Date : 14-01-2020
Application Number : 04276012IP3
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Tablet
Brand Name : Abilify
Dosage Strength : 30MG
Packaging :
Approval Date : 24-06-2004
Application Number : 4276017
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Oral Solution
Brand Name : Abilify
Dosage Strength : 1MG
Packaging :
Approval Date : 16-12-2005
Application Number : 4276033
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Oral Solution
Brand Name : Abilify
Dosage Strength : 1MG
Packaging :
Approval Date : 16-12-2005
Application Number : 4276035
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Powder And Solvent For I...
Brand Name : Abilify Maintena
Dosage Strength : 300MG
Packaging :
Approval Date : 11-03-2014
Application Number : 113882003
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Tablet
Brand Name : Abilify
Dosage Strength : 10MG
Packaging :
Approval Date : 22-01-2019
Application Number : 04276007IP2
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Tablet
Brand Name : Abilify
Dosage Strength : 10MG
Packaging :
Approval Date : 27-05-2024
Application Number : 04276007IP4
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Powder And Solvent For I...
Brand Name : Abilify Maintena
Dosage Strength : 400MG
Packaging :
Approval Date : 11-03-2014
Application Number : 113882002
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Dispersible Tablet
Brand Name : Abilify
Dosage Strength : 10MG
Packaging :
Approval Date : 24-07-2020
Application Number : 04276025IP
Regulatory Info : Authorized
Registration Country : Spain
Otsuka Holdings is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find Difamilast bulk with DMF offered by Otsuka Holdings
Find Oranekishijin hydrochloride hydrate bulk with JDMF offered by Otsuka Holdings
Find Aripiprazole bulk offered by Otsuka Holdings
